Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
The Top Healthcare Stocks to Buy With $100
02:00pm, Friday, 09'th Jun 2023
Teladoc and Axsome offer solid growth potential and are in the early days of their growth stories. Pfizer offers passive income while investors wait for this pharma-giant's new phase of growth to begi
Why Is Axsome (AXSM) Down 2.5% Since Last Earnings Report?
12:34pm, Wednesday, 07'th Jun 2023
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
07:00am, Thursday, 01'st Jun 2023
Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apnea Cognitive improvement with Sunosi sustained over eight hours i
Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with
Prediction: These 2 Stocks Could Double In the Next Year
10:15am, Sunday, 28'th May 2023
CRISPR Therapeutics is awaiting approval for a potential multi-billion product. Axsome Therapeutics has several clinical and regulatory milestones ahead.
2 Biotech Stocks That Could Help Set You Up for Life
09:37am, Friday, 26'th May 2023
Axsome has two approved treatments as well as candidates in late-stage development Vertex has the dominant treatment for cystic fibrosis and is developing other products.
2 Bear Market Defying Stocks to Buy in May
07:45am, Monday, 22'nd May 2023
Sanofi's wide lineup of medicines across several therapeutic areas makes it attractive. Axsome Therapeutics is rising in prominence thanks to an exciting pipeline.
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
09:30am, Saturday, 20'th May 2023
Axsome has several catalysts in the works that could boost its stock price. Exelixis is working on new drugs to expand its footprint in oncology.
Is a Victory for Its Rivals Bad News for Axsome Therapeutics?
05:30am, Wednesday, 17'th May 2023
The partnership of Otsuka Pharmaceutical and Lundbeck beat Axsome to market with the first approved treatment for Alzheimer's disease agitation. Axsome reported strong clinical trail data from its can
3 Growth Stocks to Buy and Hold
08:00am, Saturday, 13'th May 2023
Axsome's relatively new approval was only the first step in an exciting growth story. Eli Lilly has a strong pipeline that will help improve its already-solid financial results.
2 Magnificent Growth Stocks You Can Buy With $150 Right Now
05:11am, Wednesday, 10'th May 2023
Investing in growth stocks can be far less risky if you make smaller, more frequent purchases of your favorite companies. Axsome Therapeutics is a commercial-stage drugmaker that recently launched a n
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
03:37pm, Tuesday, 09'th May 2023
Axsome launched its first in-house developed drug last year -- the antidepressant Auvelity. In its first full quarter of commercialization, Auvelity reached more than 30,000 patients.
Axsome (AXSM) Q1 Earnings Beat Estimates, Auvelity Volume Rises
10:42am, Tuesday, 09'th May 2023
Axsome (AXSM) incurs a narrower-than-expected loss in 1Q23. Its revenues beat estimates and stock gains.
Axsome Therapeutics, Inc. (AXSM) Q1 2023 Earnings Call Transcript
02:22pm, Monday, 08'th May 2023
Axsome Therapeutics, Inc. (NASDAQ:AXSM ) Q1 2023 Earnings Conference Call May 8, 2023 8:00 AM ET Company Participants Mark Jacobson - Investor Relations Herriot Tabuteau - Chief Executive Officer Nick
Axsome Therapeutics (AXSM) Reports Q1 Loss, Tops Revenue Estimates
09:54am, Monday, 08'th May 2023
Axsome Therapeutics (AXSM) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to loss of $1.03 per share a year ago.
